Edition:
India

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

5.62USD
20 Jul 2018
Change (% chg)

$-0.20 (-3.44%)
Prev Close
$5.82
Open
$5.80
Day's High
$5.85
Day's Low
$5.57
Volume
86,158
Avg. Vol
146,902
52-wk High
$9.49
52-wk Low
$1.29

Chart for

About

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, which are mediators of biologic and pathologic functions. It uses naturally... (more)

Overall

Beta: 2.59
Market Cap(Mil.): $85.53
Shares Outstanding(Mil.): 35.05
Dividend: --
Yield (%): --

Financials

BRIEF-Galectin Therapeutics Provides Business Update

* GALECTIN THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

29 Mar 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF82.20 +1.24
Merck & Co., Inc. (MRK.N) $62.52 +0.01
Roche Holding Ltd. (ROG.S) CHF234.00 +2.05
Roche Holding Ltd. (RO.S) CHF238.60 +2.80
Eli Lilly And Co (LLY.N) $88.47 -0.96
Momenta Pharmaceuticals, Inc. (MNTA.OQ) $30.35 +0.40

Earnings vs. Estimates